ReviewMolecules (Basel, Switzerland)2021

Recent Developments in Targeting RAS Downstream Effectors for RAS-Driven Cancer Therapy.

Ozge Tatli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.